Related Experiment Videos

High risk of systemic embolism in hypertrophic cardiomyopathy

Insights

Patients with hypertrophic cardiomyopathy and atrial fibrillation face a significant risk of embolic events, including cerebral embolism. Early detection and management are crucial for preventing systemic embolism in these high-risk individuals.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
  • Systemic embolism is a potential complication in cardiovascular diseases.
  • Atrial fibrillation is a known risk factor for embolic events.

Purpose of the Study:

  • To determine the incidence of systemic embolism in patients with hypertrophic cardiomyopathy.
  • To identify risk factors and clinical characteristics associated with embolic events in HCM patients.

Main Methods:

  • Retrospective analysis of 66 patients with hypertrophic cardiomyopathy.
  • Average observation period of 3.73 years.
  • Documentation of embolic events, including type and location.

Main Results:

  • Six out of 66 patients (9.1%) experienced embolic events.
  • Incidence of systemic embolism was 2.4% per patient-year.
  • All embolic events occurred in patients with concomitant atrial fibrillation.
  • Patients with embolism showed higher cardiothoracic ratio, lower cardiac index, and larger left atrial dimension.

Conclusions:

  • Atrial fibrillation significantly increases the risk of systemic embolism in hypertrophic cardiomyopathy patients.
  • Specific echocardiographic findings may indicate higher embolic risk.
  • Further research is warranted to explore preventative strategies for embolic events in HCM.

Related Concept Videos